About Us Conditions and Treatment Support Resources Research Info How to help How to contact us

 
 

Home > Conditions and Treatment

Conditions and Treatment

Uveitis is a rare medical illness that affects vision. Uveitis is the third leading cause of preventable blindness in the developed world.  Uveitis affects children, adults, and the elderly and is found worldwide in every race.

Facts

Our thanks to the Ocular Immunology and Uveitis Foundation for permission to reprint material for this article (Sources:  Spring 2006 Newsletter, and the Uveitis Glossary). 

Destructive inflammatory diseases of the eye such as uveitis are the third leading cause of preventable blindness in developed countries

Uveitis has an estimated prevalence of about 38 cases per 100,000 population, and an incidence of 15 cases per 100,000 population.  2,359,242 people worldwide are estimated to have the disorder. 

Based on the year 2000 census, 12,275 people in Canada are estimated to have the disorder.  4,850 new cases are diagnosed each year.  Recent (2001) epidemiological studies in the United States suggest that these figures may be underestimated by as much as 4 to 5 fold.

Historically, uveitis was considered a single disease entity; however, we now know that uveitis can be caused by autoimmune disorders, infections, malignancy, and exposure to toxins.

There are approximately 85 causes of uveitis, although despite huge advances in current diagnostic techniques, 35-50% remain in the idiopathic category or unknown cause.

Because the treatment and prognosis of various uveitic entities varies greatly, accurate diagnosis is imperative.

The mean age of onset is 30.7 years (+/-15) and of that 5% to 10% of the cases occur in children under the age of 16. Uveitis in children blinds a larger percentage of those affected than in adults.

Despite significant advances in research and therapeutics, the prevalence of blindness secondary to uveitis has not been reduced in the past thirty years; it remains the third leading cause of preventable blindness in the world. 10% will go blind if current trends hold.

The sight-threatening complications of uveitis include glaucoma, damage to the retina, and macular edema.

Uveitis in children: 5% to 10% of the cases of uveitis occur in children under the age of 16. But uveitis in children blinds a larger percentage of those affected than in adults, since 40% of the cases occurring in children are posterior uveitis, compared to the 20% of posterior uveitic cases in the adult uveitis population. There are, at any one time, approximately 11,000 cases of Pediatric Uveitis in the United States, with 4,300 new cases occurring each year. The sight-threatening complications of uveitis include glaucoma, damage to the retina, and macular edema.

 

Learn About Uveitis and Ocular Inflammatory Disease

Click and read: Uveitis: A Guide for Teachers and Parents

Learn about How Uveitis is Treated

 

Search the Medical Literature Using PubMed

Click on one of these topics to read abstracts of the latest medical literature:

Uveitis
Autoimmune Uveitis and its Treatment
Pediatric uveitis
Clinical trials in pediatric uveitis
Uveitis treatment
Uveitis and glaucoma
Recent publications by Dr. Foster (PubMed)

Additional InformationClick and explore the Uveitis Glossary

Ocular Immunology and Uveitis Foundation
Cambridge, MA USA

http://www.uveitis.org

 

Uveitis Glossary

http://www.uveitis.org/patient/glossary/

 

National Eye Institute
2020 Vision Place
Bethesda, MD 20892-3655
Phone: (301) 496-5248
http://www.nei.nih.gov/

Diagnosis and Treatment of Uveitis (CS Foster, 2002)

Diagnosis and Treatment of Uveitis

Foster CS, Vitale A. (2002).

This is a medical textbook.  It can also be ordered by patients.  Click for ordering details:   W. B. Saunders, publishers.

 

OUR MEDICAL ADVISORS

Calgary Retina Consultants

Amin Kherani, BSc, MD, FRCSC

Founder

Website:  www.calgaryretina.ca

Calgary Retina Consultants, under the leadership of Dr. Kherani and Dr. Avril Fitzgerald, have created a uveitis treatment center that combines the latest in ophthalmic and rheumatologic care.

Ocular Immunology and Uveitis Foundation

C. Stephen Foster, M.D., FACS
Founder and President

 

Website:  www.uveitis.org

Ocular Immunology and Uveitis Foundation

The Ocular Immunology and Uveitis Foundation (OIUF) is the only non-profit voluntary health organization in the world dedicated exclusively to finding the causes and cure for uveitis and other ocular inflammatory diseases and is the only organization exclusively serving individuals, families and friends affected by uveitis.

The Foundation is located at the Massachusetts Eye Research and Surgery Institute (MERSI), a medical institute headed by C. Stephen Foster, M.D., that is devoted exclusively to the care and treatment of adults and children with ocular inflammatory disease, and to the training of the next generation of specialist physicians (website link).

Learn more about the OIUF:

Current research activities  |

How to help |  Newsletter 

Brochure MERSI

 

IMPORTANT LINKS

CINB logo 

CNIB:   www.cnib.ca

CNIB is a nationwide, community-based, registered charity committed to public education, research and the vision health of all Canadians. CNIB provides the services and support necessary to enjoy a good quality of life while living with vision loss.

 

Uveitis Support | Canada is a nonprofit, public charity established in 2006 by the Alberta Uveitis Society to educate and support patients and family members living with ocular inflammatory disease and their physicians.  Uveitis Support | Canada is a chapter of the Uveitis/OID Support Group, a program of the  Ocular Immunology and Uveitis Foundation.

Uveitis Support | Canada  ~ 119 Hidden Ranch Place NW  ~  Calgary AB T3A 5N8  ~ Email: Info@uveitis.ca
Copyright © 2006 Uveitis Support | Canada.  All Rights Reserved.